Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PSYT 301 > Lecture 4: cocaine > Flashcards

Lecture 4: cocaine Flashcards

1
Q

what are the priorities of the Cannabis act?

A
  • Protect the health of young persons by restricting their access to cannabis
  • Minimize inducements to use cannabis
  • Allow the legal production of cannabis to replace the illicit market
  • Deter illicit cannabis production and sale
  • Reduce the burden of dealing with cannabis offences imposed on the
    criminal justice system
  • Enable cannabis users to have a quality-controlled supply of cannabis
  • Increase public awareness of the health risks of using cannabis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

did the cannabis act work?

A

not really since the rate of cannabis use increased, and many are using daily, which is associated with physical and mental health problems

although it has decreased slightly in youth, it has not significantly decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

which population represent the fastest growing population
of cannabis users in Canada?

A

the aging adults (55 and older)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the consequences of cannabis legalization?

A
  1. Decreased perceived harmfulness (People perceive cannabis to be beneficial rather than harmful, most people think it has no effect)
  2. Increased cannabis availability and accessibility (sales are rising exponentially)
  3. Outcomes related to health have increased or remained steady since legalization
  4. But….. Substantial reductions in criminal arrests and charges related to cannabis use and related stigma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is cannabis?

A

a substance derived from Cannabaceae family of plants that has stimulant, depressant, and hallucinogenic properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are some compounds found in cannabis?

A

> 80 cannabinoids
* Terpenes
* Flavonoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what do Terpenes do?

A

responsible for the aroma of cannabis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what do flavonoids do?

A

pigment and flavor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the most common cannabinoids?

A

THC and CBD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

is THC and CBD psychoactive and addictive?

A

THC: psychoactive and addictive
CBD: psychoactive and not addictive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the 3 families of cannabis?

A
  • Cannabis sativa: contains a higher ratio of THC to CBD, producing more stimulating, psychotropic effects
  • Cannabis indica: contains a higher ratio of CBD:THC and is typically more sedating
  • Ruderalis: contains low THC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what does the mode of administration affect?

A

different onset of effects, duration of action and distinct health effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the most common modes of adminstrations?

A

dried flower/leaf, edible products, vapes, oils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The Endocannabinoid system is a widespread __________ system

A

neuromodulatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

the endocannabinoid system is import for what processes?

A
  • CNS development
  • Regulates many physiological and cognitive processes
  • works to maintain homeostasis (Controls the level and activity of other neurotransmitters and influences many signaling pathways)
  • implicated in pathological conditions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what makes up the endogenous cannabinoid system?

A

endocannabinoids, cannabinoid receptors, endocannabinoid enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are the different forms of cannabinoids?

A
  • Phytocannabinoids - derived naturally from flora
  • Endocannabinoids - produced endogenously
  • Synthetic Cannabinoids – created artificially
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how does the endogenous cannabinoid system work?

A
  1. Lipid molecules synthesized on demand
  2. “Retrograde” messengers: released from postsynaptic cells and travel backwards across the synapse
  3. Bind to cannabinoid receptors located on the presynaptic cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what are the best characterized endocannabinoids?

A

anandamide and 2-arachidonylglycerol (2-AG)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what are the 2 enzymes part of the endocannabinoid system?

A

Fatty acid amino hydrolase (FAAH) and monoacylglycerol lipase (MAGL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

role of FAAH

A

degrade anandamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

role of MAGL

A

degrade 2-AG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what are the 2 types of cannabinoid receptors? where are they predominantly found?

A
  • CB1R – predominantly found in the central nervous system
  • CB2R – predominantly found in the periphery and immune cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

which receptor does anandamide and 2-AG bind to?

A

Anandamide is a partial agonist at CB1R and CB2R

2-AG is a full agonist at CB1R and CB2R

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

where are there high concentrations of CB1R in the brain? what are the implications here?

A

basal ganglia (movement control), nucleus accumbens (reward and motivation), cerebellum (movement coordination)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

how is THC metabolized?

A

Metabolized into active Hydroxy THC (11-OH-THC) and inactive Carboxy-THC (THC-COOH) by Cytochrome P450 enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

how is THC stored and excreted?

A

Deposits in adipose tissue and later re-released into blood
- Long half-life (20-30 hours)
- Metabolites remain detectable for ~ 28 days after last use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what are the pharmacokinetics of smoking THC?

A

THC is rapidly absorbed through lungs after inhalation quickly reaching peak
concentration in blood 6-10 min post-inhalation and brain within 15 to 30 min

THC is highly lipid soluble. It
is rapidly taken up by fat
tissue where it accumulates
reaching peak concentration
4-5 days later. From these
fat deposits, THC is slowly
released back into the
bloodstream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

why is cannabis addictive?

A

THC dose-dependently increases dopamine in the shell of nucleus accumbens

THC increases dopamine indirectly via decreasing GABAergic inhibition of dopamine neural activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

what is the capture rate of cannabis?

A

9.1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

how does THC potency change with time?

A

increases with time (today may be up to 20%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

what are some short-term effects of THC?

A
  • red eyes
  • dry mouth
  • skin sensation
  • memory loss
  • paranoia
  • impaired motor coordination
  • increased appetite
  • pleasure/bliss
  • delayed response
  • altered perception
  • muscle relaxation
  • increased heart rate
33
Q

what are acute responses for very high doses of THC?

A
  • Chest pain
  • Rapid heartbeat
  • Nausea/vomiting
  • Psychotic episode - hallucinations/delusions
  • Respiratory depression
34
Q

what are long-term effects of THC?

A
  • Physical Health Risks: respiratory and cardiovascular problems
  • Psychiatric Symptoms and Disorders: cannabis addiction, depression, anxiety, psychosis
  • Psychosocial Problems: poor academic and employment performance, socially withdrawn
  • Cognitive Dysfunction: memory impairment
35
Q

what are neurobiological changes seen with chronic cannabis use?

A

CB1Rs are downregulated in CUD participants

Amygdala volume negatively correlated with severity of CUD; hippocampus volume negatively correlated with weekly cannabis use

36
Q

what are the therapeutic properties of CBD?

A

Anxiolytic, antidepressant, antipsychotic, analgesic, anti-inflammatory

Has been studied as an add-on therapy for social anxiety disorders, schizophrenia, non-motor symptoms in Parkinson’s disease, and substance use disorders

There is a lack of evidence to support many of these claims

37
Q

effect of CBD

A

Non-competitive negative allosteric modulator of CB1R
- Reduces the affinity/efficacy of THC and anandamide
- Improves tolerability and safety of THC by antagonizing adverse effects of THC

Inhibits FAAH

38
Q

what are some non-cannabinoid targets of CBD?

A
  • Agonist at the serotonin 5-HT1A receptor
  • Allosteric modulation of opioid receptors
  • Agonist at transient potential vanilloid-1 receptors (TRPV1) – multisensory receptor
39
Q

what are the CBD pharmacokinetics?

A

Metabolized by cytochromes P450 (CYPs) 2C9, 2C19, and 3A4
* Active metabolite: 7-hydroxy-CBD (7-OH-CBD)
* Inactive metabolite: 7-carboxy-CBD (CBD-COOH)

Lipid soluble
* Prolonged elimination
* Half life 1 hours – 30 hours (variation between studies)

40
Q

side effects of CBD

A
  • Decreased alertness (e.g., drowsiness and sedation)
  • Changes in mood (e.g., irritability and agitation)
  • Decreased appetite, gastrointestinal symptoms/distress (e.g., diarrhea)
  • Drug interaction effects with over-the-counter and prescription medications
41
Q

what are the targets of synthetic cannabinoids?

A

Full agonist at cannabinoid receptors (Elicit maximal activation of the receptor, beyond what is achievable with THC)

Does not contain CBD

42
Q

The documented toxic effects of synthetic cannabinoids are _________ than those associated with cannabis

A

more severe and far more extensive

43
Q

what makes cannabis difficult to quit?

A

withdrawal with similar severity to tobacco

44
Q

what withdrawal symptoms are seen with cannabis withdrawal?

A
  • Cravings
  • Irritability
  • Anxiety
  • Depression
  • Decreased appetite
  • Sleep disturbances
  • Weird dreams
  • Restlessness
  • Somatic symptoms:
    headaches, sweating,
    nausea, vomiting,
    abdominal pain
    proportional to severity of cannabis use
45
Q

what is the cannabis withdrawal trajectory?

A

Follows a distinct and protracted trajectory: symptoms begin 24 hours after cessation, peak within 7 days, and dissipate following 28 days of abstinence

46
Q

what are some types of cannabis withdrawal treatments? which work better?

A

behavioural treatments, which work the best
some pharmacotherapies that target withdrawal and the harm reduction approach

47
Q

what is the harm reduction approach for cannabis use?

A
  1. avoid adding tobacco
  2. use safer routes (edible > vaporize > smoking)
  3. use a regulated supply when able (medical or recreational)
48
Q

what are the behavioural therapies to stop cannabis?

A
  • Cognitive-behavioral therapy
  • Motivational enhancement therapy
  • Contingency management
49
Q

what pharmacotherapies are used to treat cocaine withdrawal?

A
  • Sedatives (e.g., Zolpidem)
  • Antidepressants (e.g., bupropion)
  • Synthetic Cannabinoid (oral THC, nabilone)
  • CB1R antagonist (e.g., Rimonabant)
  • FAAH Inhibitor (PF-04457845)
50
Q

how well do FAAH inhibitors work to stop cannabis use?

A
  • Lower self-reported cannabis use at 4 weeks with PF-04457845 relative to placebo
  • Reduced symptoms of cannabis withdrawal
  • Lower urinary THC-COOH concentrations
  • Well tolerated
51
Q

what is self-medication?

A

using a substance to alleviate, cope with, or reduce psychological or physical symptoms

52
Q

is there evidence that medicating with cannabis works?

A

although there are some studies that show that low dose cannabis can produce anxiolytic effects for some people, more studies show that it should not be recommended for treatment

53
Q

what are consequences of cannabis use?

A

cognitive impairments, psychosis, depression, suicidality, anxiety

54
Q

what is cannabis use disorder, according to the DSM-5?

A

Problematic pattern of cannabis consumption that leads to clinically significant levels of impairment or distress to the user, manifested by at least two of the following 11 symptoms within a period of 12-months

55
Q

what are some things that makes people vulnerable to cannabis use disorder?

A
  • Daily or almost daily users
  • Adolescents and young adults, especially under the age of 25
  • Family history of addiction
  • Those with psychiatric history
56
Q

Acute intoxication has been shown to lead to _____________

A

cognitive impairments in domains like memory, learning, attention, perceptual motor skill, executive functions, and processing speed

57
Q

what are residual effects, and which symptoms are shown to have this?

A

cognitive impairments that remain after acute intoxication: memory, verbal learning, executive functioning, attention, processing speed, and language

58
Q

Cannabis can have negative effects on the ________ of
_______________ (group of people)

A

functioning of
students at school

59
Q

how does vulnerabilities to residual deficits change with age?

A

Potential age-dependent deficits in different brain structures

60
Q

what is psychosis?

A

Mental state/behaviours characterized by a “loss of contact with reality” with or without presence of hallucinations and delusions

61
Q

what are hallucinations and delusions?

A

hallucinations: disorder in the experience of sensory events (e.g. see or hear aren’t there)
delusions: disorder in the representation of reality (e.g. delusions of persecution, grandiosity, paranoia)

62
Q

what are the symptoms of schizophrenia?

A
  • Positive symptoms: hallucinations and/or delusions
  • Negative symptoms: flat affect, avolition, anhedonia, alogia
  • Disorganized symptoms: disorganized speech, inappropriate affect
63
Q

what is the dose-dependent relationship seen with cannabis on psychosis symtoms?

A
  • Low [THC]: anxiolytic ~ feeling calm, less anxious, relaxed, slowed down
  • High [THC]: can produce feelings of anxiety, hallucinations, delusions (e.g. paranoia), derealization
64
Q

upon THC administration to people without CUD, but that have already used cannabis, what symptoms can be seen?

A
  • Positive symptoms (similar to patient with SCZ)
  • Negative symptoms
  • Perceptual alterations (e.g. spaced out, detached)
  • Anxious
  • Tired
65
Q

Cannabis use is a risk factor to the development of ___________

A

schizophrenia

66
Q

what are factors that affect the prevalence of SCZ development with cannabis use?

A
  1. Dose-response relationship
  2. Sex Effects
    (The link between CUD and SCZ is more prevalent in males)
  3. Timing of use
    (Using in adolescence increases the strength in the relationship between cannabis use and SCZ)
  4. Genetics
    (Polymorphisms: COMT, AKT1, DAT1, BDNF)
67
Q

what is the role of COMT?

A

enzyme responsible for the breakdown of dopamine in the brain, on the surface of the receptor

68
Q

what are the two explanations that can be seen for the trend where students that report consuming cannabis frequently are also meeting the criteria for anxiety and depression?

A

causal relationship (Substance-induced pathway) and reverse-causal relationship (symptom-driven pathway)

69
Q

Adolescent cannabis use was associated with adult ____ and
_______, but not with _____.

A

MDD and
suicidality, but not with GAD.

70
Q

with depression, Factors like _______ and __________ increased risk

A

young age of use and
increased frequency

71
Q

Greater cannabis use at baseline predicted ____________ in anxiety –> _______________

A

slower improvements; maintenance of symptoms over time

72
Q

was the reverse-causal hypothesis supported for anxiety and cannabis use?

A

no, anxiety at baseline did not predict change in cannabis use

73
Q

what is flourishing?

A

the presence of positive mental health inclusive of emotional, psychological and social prosperity and is a good indicator of overall wellbeing

74
Q

how is flourishing associated with cannabis use?

A

Even after controlling for depression and anxiety symptoms, flourishing was a better predictor of cannabis use levels: Flourishing was associated with lower cannabis use

75
Q

what is the evidence for dysregulation of endocannabinoid system after chronic
cannabis use?

A
  1. Downregulation of CB1r
  2. Dysregulation in plasma and CSF endocannabinoid levels
76
Q

what is the abstinence paradigm and what did it show?

A
  • Participants with a CUD quit cannabis for 28 days to measure changes in different outcomes.
  • Cannabis withdrawal symptoms have an onset of 24-48hours (then decrease over time)
77
Q

why choose 28 days for the abstinence paradigm?

A
  • Coincides with the complete urinary elimination of cannabis
  • Most withdrawal symptoms dissipate after 28 days of cannabis abstinence
  • Evidence that downregulation of CB1r reverses after 28 days of cannabis abstinence
78
Q

With abstinence, withdrawal symptoms peak on day __ and dissipate over __ days

A

7 ; 28

79
Q

when looking at cannabis abstinence and depression, how are they linked?

A

Depressive symptoms returned to baseline, which provides evidence that cannabis does not remedy depressive symptoms

PSYT 301 (4 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions